HEADER ISOMERASE/IMMUNOSUPPRESSANT 08-MAR-13 4JJM TITLE STRUCTURE OF A CYCLOPHILIN FROM CITRUS SINENSIS (CSCYP) IN COMPLEX TITLE 2 WITH CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 5.2.1.8; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CYCLOSPORIN A; COMPND 8 CHAIN: E, F; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CITRUS SINENSIS; SOURCE 3 ORGANISM_COMMON: VALENCIA ORANGE,APFELSINE,NARANJA,NAVEL ORANGE, SOURCE 4 SWEET ORANGE; SOURCE 5 ORGANISM_TAXID: 2711; SOURCE 6 GENE: CYP; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 15 ORGANISM_TAXID: 29910 KEYWDS CYCLOPHILIN, ISOMERASE-IMMUNOSUPPRESSANT COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.M.CAMPOS,A.L.B.AMBROSIO,T.A.C.B.SOUZA,J.A.R.G.BARBOSA,C.E.BENEDETTI REVDAT 6 06-DEC-23 4JJM 1 LINK REVDAT 5 20-SEP-23 4JJM 1 SEQADV LINK REVDAT 4 05-DEC-18 4JJM 1 TITLE REVDAT 3 21-JUN-17 4JJM 1 JRNL REVDAT 2 17-JUL-13 4JJM 1 JRNL REVDAT 1 12-JUN-13 4JJM 0 JRNL AUTH B.M.CAMPOS,M.L.SFORCA,A.L.AMBROSIO,M.N.DOMINGUES, JRNL AUTH 2 A.BRASIL DE SOUZA TDE,J.A.R.G.BARBOSA,A.F.PAES LEME, JRNL AUTH 3 C.A.PEREZ,S.B.WHITTAKER,M.T.MURAKAMI,A.C.ZERI,C.E.BENEDETTI JRNL TITL A REDOX 2-CYS MECHANISM REGULATES THE CATALYTIC ACTIVITY OF JRNL TITL 2 DIVERGENT CYCLOPHILINS. JRNL REF PLANT PHYSIOL. V. 162 1311 2013 JRNL REFN ISSN 0032-0889 JRNL PMID 23709667 JRNL DOI 10.1104/PP.113.218339 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20811 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1068 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.5292 - 4.1764 1.00 2601 134 0.1544 0.1754 REMARK 3 2 4.1764 - 3.3156 1.00 2494 132 0.1489 0.1905 REMARK 3 3 3.3156 - 2.8967 1.00 2450 143 0.1866 0.2323 REMARK 3 4 2.8967 - 2.6319 1.00 2476 111 0.1925 0.2671 REMARK 3 5 2.6319 - 2.4433 1.00 2450 134 0.2050 0.2481 REMARK 3 6 2.4433 - 2.2992 1.00 2417 146 0.2019 0.2651 REMARK 3 7 2.2992 - 2.1841 1.00 2445 130 0.2045 0.2517 REMARK 3 8 2.1841 - 2.0900 1.00 2410 138 0.2210 0.2934 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2722 REMARK 3 ANGLE : 1.029 3670 REMARK 3 CHIRALITY : 0.295 401 REMARK 3 PLANARITY : 0.004 487 REMARK 3 DIHEDRAL : 14.171 970 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4JJM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-13. REMARK 100 THE DEPOSITION ID IS D_1000078128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LNLS REMARK 200 BEAMLINE : W01B-MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.458 REMARK 200 MONOCHROMATOR : SI 111 DOUBLE FLAT CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20834 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 37.523 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.19600 REMARK 200 R SYM (I) : 0.19600 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.67900 REMARK 200 R SYM FOR SHELL (I) : 0.67900 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1DYW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS PROPANE, 1.2 M SODIUM REMARK 280 CITRATE, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.68667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.34333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.34333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 56.68667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 271 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 SER B 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MLE E 3 O - C - N ANGL. DEV. = -14.2 DEGREES REMARK 500 MVA F 4 O - C - N ANGL. DEV. = 11.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 67 -79.17 -122.64 REMARK 500 THR A 75 -60.40 -92.64 REMARK 500 ALA A 124 -174.85 -170.50 REMARK 500 PHE B 67 -82.92 -125.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF CYCLOSPORIN A DBREF 4JJM A 1 172 UNP D0ELH5 D0ELH5_CITSI 1 172 DBREF 4JJM B 1 172 UNP D0ELH5 D0ELH5_CITSI 1 172 DBREF 4JJM F 1 11 NOR NOR00033 NOR00033 1 11 DBREF 4JJM E 1 11 NOR NOR00033 NOR00033 1 11 SEQADV 4JJM GLY A -2 UNP D0ELH5 EXPRESSION TAG SEQADV 4JJM SER A -1 UNP D0ELH5 EXPRESSION TAG SEQADV 4JJM HIS A 0 UNP D0ELH5 EXPRESSION TAG SEQADV 4JJM GLY B -2 UNP D0ELH5 EXPRESSION TAG SEQADV 4JJM SER B -1 UNP D0ELH5 EXPRESSION TAG SEQADV 4JJM HIS B 0 UNP D0ELH5 EXPRESSION TAG SEQRES 1 A 175 GLY SER HIS MET PRO ASN PRO LYS VAL PHE PHE ASP MET SEQRES 2 A 175 THR VAL GLY GLY GLN PRO ALA GLY ARG ILE VAL MET GLU SEQRES 3 A 175 LEU PHE ALA ASP VAL THR PRO ARG THR ALA GLU ASN PHE SEQRES 4 A 175 ARG ALA LEU CYS THR GLY GLU LYS GLY ILE GLY LYS SER SEQRES 5 A 175 GLY LYS PRO LEU HIS TYR LYS GLY SER SER PHE HIS ARG SEQRES 6 A 175 VAL ILE PRO GLY PHE MET CYS GLN GLY GLY ASP PHE THR SEQRES 7 A 175 ALA GLY ASN GLY THR GLY GLY GLU SER ILE TYR GLY SER SEQRES 8 A 175 LYS PHE ALA ASP GLU ASN PHE VAL LYS LYS HIS THR GLY SEQRES 9 A 175 PRO GLY ILE LEU SER MET ALA ASN ALA GLY PRO GLY THR SEQRES 10 A 175 ASN GLY SER GLN PHE PHE VAL CYS THR ALA LYS THR GLU SEQRES 11 A 175 TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY GLN VAL VAL SEQRES 12 A 175 GLU GLY MET ASP VAL VAL LYS ALA ILE GLU LYS VAL GLY SEQRES 13 A 175 SER SER SER GLY ARG THR ASN LYS PRO VAL VAL ILE ALA SEQRES 14 A 175 ASP CYS GLY GLN LEU SER SEQRES 1 B 175 GLY SER HIS MET PRO ASN PRO LYS VAL PHE PHE ASP MET SEQRES 2 B 175 THR VAL GLY GLY GLN PRO ALA GLY ARG ILE VAL MET GLU SEQRES 3 B 175 LEU PHE ALA ASP VAL THR PRO ARG THR ALA GLU ASN PHE SEQRES 4 B 175 ARG ALA LEU CYS THR GLY GLU LYS GLY ILE GLY LYS SER SEQRES 5 B 175 GLY LYS PRO LEU HIS TYR LYS GLY SER SER PHE HIS ARG SEQRES 6 B 175 VAL ILE PRO GLY PHE MET CYS GLN GLY GLY ASP PHE THR SEQRES 7 B 175 ALA GLY ASN GLY THR GLY GLY GLU SER ILE TYR GLY SER SEQRES 8 B 175 LYS PHE ALA ASP GLU ASN PHE VAL LYS LYS HIS THR GLY SEQRES 9 B 175 PRO GLY ILE LEU SER MET ALA ASN ALA GLY PRO GLY THR SEQRES 10 B 175 ASN GLY SER GLN PHE PHE VAL CYS THR ALA LYS THR GLU SEQRES 11 B 175 TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY GLN VAL VAL SEQRES 12 B 175 GLU GLY MET ASP VAL VAL LYS ALA ILE GLU LYS VAL GLY SEQRES 13 B 175 SER SER SER GLY ARG THR ASN LYS PRO VAL VAL ILE ALA SEQRES 14 B 175 ASP CYS GLY GLN LEU SER SEQRES 1 E 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA MODRES 4JJM MLE E 2 LEU N-METHYLLEUCINE MODRES 4JJM MLE E 3 LEU N-METHYLLEUCINE MODRES 4JJM MVA E 4 VAL N-METHYLVALINE MODRES 4JJM BMT E 5 THR MODRES 4JJM ABA E 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 4JJM SAR E 7 GLY SARCOSINE MODRES 4JJM MLE E 8 LEU N-METHYLLEUCINE MODRES 4JJM MLE E 10 LEU N-METHYLLEUCINE MODRES 4JJM MLE F 2 LEU N-METHYLLEUCINE MODRES 4JJM MLE F 3 LEU N-METHYLLEUCINE MODRES 4JJM MVA F 4 VAL N-METHYLVALINE MODRES 4JJM BMT F 5 THR MODRES 4JJM ABA F 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 4JJM SAR F 7 GLY SARCOSINE MODRES 4JJM MLE F 8 LEU N-METHYLLEUCINE MODRES 4JJM MLE F 10 LEU N-METHYLLEUCINE HET DAL E 1 5 HET MLE E 2 9 HET MLE E 3 9 HET MVA E 4 8 HET BMT E 5 13 HET ABA E 6 6 HET SAR E 7 5 HET MLE E 8 9 HET MLE E 10 9 HET DAL F 1 5 HET MLE F 2 9 HET MLE F 3 9 HET MVA F 4 8 HET BMT F 5 13 HET ABA F 6 6 HET SAR F 7 5 HET MLE F 8 9 HET MLE F 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 8(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 BMT 2(C10 H19 N O3) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 5 HOH *288(H2 O) HELIX 1 1 THR A 29 GLY A 42 1 14 HELIX 2 2 THR A 126 ASP A 130 5 5 HELIX 3 3 GLY A 142 VAL A 152 1 11 HELIX 4 4 THR B 29 GLY B 42 1 14 HELIX 5 5 THR B 126 ASP B 130 5 5 HELIX 6 6 GLY B 142 LYS B 151 1 10 SHEET 1 A 8 PHE A 60 ILE A 64 0 SHEET 2 A 8 MET A 68 GLY A 71 -1 O GLN A 70 N ARG A 62 SHEET 3 A 8 PHE A 119 CYS A 122 -1 O VAL A 121 N CYS A 69 SHEET 4 A 8 ILE A 104 MET A 107 -1 N SER A 106 O PHE A 120 SHEET 5 A 8 VAL A 135 GLU A 141 -1 O GLY A 137 N LEU A 105 SHEET 6 A 8 GLN A 15 LEU A 24 -1 N VAL A 21 O VAL A 140 SHEET 7 A 8 LYS A 5 VAL A 12 -1 N VAL A 6 O MET A 22 SHEET 8 A 8 VAL A 163 SER A 172 -1 O LEU A 171 N LYS A 5 SHEET 1 B 8 ARG B 62 ILE B 64 0 SHEET 2 B 8 MET B 68 GLY B 71 -1 O GLN B 70 N ARG B 62 SHEET 3 B 8 PHE B 119 CYS B 122 -1 O PHE B 119 N GLY B 71 SHEET 4 B 8 ILE B 104 MET B 107 -1 N ILE B 104 O CYS B 122 SHEET 5 B 8 VAL B 135 GLU B 141 -1 O GLY B 137 N LEU B 105 SHEET 6 B 8 GLN B 15 LEU B 24 -1 N GLU B 23 O GLN B 138 SHEET 7 B 8 LYS B 5 VAL B 12 -1 N VAL B 6 O MET B 22 SHEET 8 B 8 VAL B 163 LEU B 171 -1 O ASP B 167 N ASP B 9 LINK C DAL E 1 N MLE E 2 1555 1555 1.33 LINK N DAL E 1 C ALA E 11 1555 1555 1.33 LINK C MLE E 2 N MLE E 3 1555 1555 1.33 LINK C MLE E 3 N MVA E 4 1555 1555 1.27 LINK C MVA E 4 N BMT E 5 1555 1555 1.37 LINK C BMT E 5 N ABA E 6 1555 1555 1.26 LINK C ABA E 6 N SAR E 7 1555 1555 1.33 LINK C SAR E 7 N MLE E 8 1555 1555 1.33 LINK C MLE E 8 N VAL E 9 1555 1555 1.33 LINK C VAL E 9 N MLE E 10 1555 1555 1.33 LINK C MLE E 10 N ALA E 11 1555 1555 1.33 LINK C DAL F 1 N MLE F 2 1555 1555 1.33 LINK N DAL F 1 C ALA F 11 1555 1555 1.33 LINK C MLE F 2 N MLE F 3 1555 1555 1.33 LINK C MLE F 3 N MVA F 4 1555 1555 1.25 LINK C MVA F 4 N BMT F 5 1555 1555 1.30 LINK C BMT F 5 N ABA F 6 1555 1555 1.39 LINK C ABA F 6 N SAR F 7 1555 1555 1.33 LINK C SAR F 7 N MLE F 8 1555 1555 1.33 LINK C MLE F 8 N VAL F 9 1555 1555 1.33 LINK C VAL F 9 N MLE F 10 1555 1555 1.33 LINK C MLE F 10 N ALA F 11 1555 1555 1.33 SITE 1 AC1 20 ASN A 78 THR A 80 SER A 156 ARG B 62 SITE 2 AC1 20 PHE B 67 GLN B 70 GLY B 79 ALA B 108 SITE 3 AC1 20 ASN B 109 ALA B 110 GLN B 118 PHE B 120 SITE 4 AC1 20 TRP B 128 HIS B 133 HOH E 102 HOH E 104 SITE 5 AC1 20 HOH E 105 HOH E 108 SAR F 7 HOH F 101 SITE 1 AC2 19 ARG A 62 PHE A 67 GLN A 70 ALA A 108 SITE 2 AC2 19 ASN A 109 GLN A 118 PHE A 120 TRP A 128 SITE 3 AC2 19 HIS A 133 HOH A 329 PRO B 65 GLY B 66 SITE 4 AC2 19 SER B 155 MLE E 8 HOH E 104 HOH F 101 SITE 5 AC2 19 HOH F 102 HOH F 105 HOH F 106 CRYST1 83.630 83.630 85.030 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011957 0.006904 0.000000 0.00000 SCALE2 0.000000 0.013807 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011761 0.00000